FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025448962> ?p ?o ?g. }

• W2025448962 endingPage "70" @default.
• W2025448962 startingPage "67" @default.
• W2025448962 abstract "Objectives To test the dyspareunia response of patients with interstitial cystitis/painful bladder syndrome treated with an intravesical therapeutic solution of lidocaine, heparin, and sodium bicarbonate. Methods We studied consecutive patients with interstitial cystitis/painful bladder syndrome who were sexually active and were treated with an intravesical therapeutic solution. All patients provided their medical history, underwent a physical examination, and completed the Pelvic Pain Urgency Frequency symptom scale, voiding diary, and the pain domain (questions 17 to 19) of the Female Sexual Function Index before and after therapy. The patients were treated with intravesical instillations three times weekly for 3 weeks. The patients returned for follow-up 3 weeks later. The patients rated their response using a Patient Objective Rating of Improvement of Symptom scale. Results A total of 23 patients (mean age 38 years) were included in this study. Of the 23 patients, 15 (65%) reported improvements of greater than 50% on the Patient Objective Rating of Improvement of Symptom scale. Before and after instillation, nocturia was 4 ± 2 versus 2 ± 1 (P <0.001), the voided volume was 98 ± 59 mL versus 169 ± 80 mL (P <0.001), the Pelvic Pain Urgency Frequency score was 21 ± 6 versus 15 ± 6 (P <0.001), and the Female Sexual Function Index pain domain score was 1.9 ± 0.9 versus 3.7 ± 1.6 (P <0.001), respectively. Of the 23 patients, 13 (57%) reported resolution of dyspareunia. Of the 13 patients with bladder tenderness only versus the 7 with multiple tender locations on the vaginal examination, 11 (85%) versus 2 (29%) had resolution of dyspareunia (P <0.01) and 12 (92%) versus 2 (29%) had successful overall outcomes (P <0.01). Conclusions The results of this study have demonstrated that an intravesical therapeutic solution provides relief of voiding symptoms, pain, and dyspareunia in patients with interstitial cystitis/painful bladder syndrome. A randomized, prospective trial is warranted. To test the dyspareunia response of patients with interstitial cystitis/painful bladder syndrome treated with an intravesical therapeutic solution of lidocaine, heparin, and sodium bicarbonate. We studied consecutive patients with interstitial cystitis/painful bladder syndrome who were sexually active and were treated with an intravesical therapeutic solution. All patients provided their medical history, underwent a physical examination, and completed the Pelvic Pain Urgency Frequency symptom scale, voiding diary, and the pain domain (questions 17 to 19) of the Female Sexual Function Index before and after therapy. The patients were treated with intravesical instillations three times weekly for 3 weeks. The patients returned for follow-up 3 weeks later. The patients rated their response using a Patient Objective Rating of Improvement of Symptom scale. A total of 23 patients (mean age 38 years) were included in this study. Of the 23 patients, 15 (65%) reported improvements of greater than 50% on the Patient Objective Rating of Improvement of Symptom scale. Before and after instillation, nocturia was 4 ± 2 versus 2 ± 1 (P <0.001), the voided volume was 98 ± 59 mL versus 169 ± 80 mL (P <0.001), the Pelvic Pain Urgency Frequency score was 21 ± 6 versus 15 ± 6 (P <0.001), and the Female Sexual Function Index pain domain score was 1.9 ± 0.9 versus 3.7 ± 1.6 (P <0.001), respectively. Of the 23 patients, 13 (57%) reported resolution of dyspareunia. Of the 13 patients with bladder tenderness only versus the 7 with multiple tender locations on the vaginal examination, 11 (85%) versus 2 (29%) had resolution of dyspareunia (P <0.01) and 12 (92%) versus 2 (29%) had successful overall outcomes (P <0.01). The results of this study have demonstrated that an intravesical therapeutic solution provides relief of voiding symptoms, pain, and dyspareunia in patients with interstitial cystitis/painful bladder syndrome. A randomized, prospective trial is warranted." @default.
• W2025448962 created "2016-06-24" @default.
• W2025448962 creator A5080448752 @default.
• W2025448962 creator A5086848208 @default.
• W2025448962 date "2008-01-01" @default.
• W2025448962 modified "2023-10-01" @default.
• W2025448962 title "Dyspareunia Response in Patients with Interstitial Cystitis Treated with Intravesical Lidocaine, Bicarbonate, and Heparin" @default.
• W2025448962 cites W1970532536 @default.
• W2025448962 cites W2021912616 @default.
• W2025448962 cites W2027735589 @default.
• W2025448962 cites W2030236866 @default.
• W2025448962 cites W2040372471 @default.
• W2025448962 cites W2054255246 @default.
• W2025448962 cites W2054860352 @default.
• W2025448962 cites W2067732513 @default.
• W2025448962 cites W2067814588 @default.
• W2025448962 cites W2070801718 @default.
• W2025448962 cites W2087729801 @default.
• W2025448962 cites W2097282427 @default.
• W2025448962 cites W2107116520 @default.
• W2025448962 cites W2112997260 @default.
• W2025448962 cites W2129512111 @default.
• W2025448962 cites W2145585848 @default.
• W2025448962 cites W2791119031 @default.
• W2025448962 cites W2791768672 @default.
• W2025448962 doi "https://doi.org/10.1016/j.urology.2007.09.067" @default.
• W2025448962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18242367" @default.
• W2025448962 hasPublicationYear "2008" @default.
• W2025448962 type Work @default.
• W2025448962 sameAs 2025448962 @default.
• W2025448962 citedByCount "75" @default.
• W2025448962 countsByYear W20254489622012 @default.
• W2025448962 countsByYear W20254489622013 @default.
• W2025448962 countsByYear W20254489622014 @default.
• W2025448962 countsByYear W20254489622015 @default.
• W2025448962 countsByYear W20254489622016 @default.
• W2025448962 countsByYear W20254489622017 @default.
• W2025448962 countsByYear W20254489622019 @default.
• W2025448962 countsByYear W20254489622020 @default.
• W2025448962 countsByYear W20254489622021 @default.
• W2025448962 countsByYear W20254489622022 @default.
• W2025448962 countsByYear W20254489622023 @default.
• W2025448962 crossrefType "journal-article" @default.
• W2025448962 hasAuthorship W2025448962A5080448752 @default.
• W2025448962 hasAuthorship W2025448962A5086848208 @default.
• W2025448962 hasConcept C126322002 @default.
• W2025448962 hasConcept C126894567 @default.
• W2025448962 hasConcept C141071460 @default.
• W2025448962 hasConcept C2775871022 @default.
• W2025448962 hasConcept C2777333188 @default.
• W2025448962 hasConcept C2778508898 @default.
• W2025448962 hasConcept C2780136519 @default.
• W2025448962 hasConcept C2780149897 @default.
• W2025448962 hasConcept C42219234 @default.
• W2025448962 hasConcept C71924100 @default.
• W2025448962 hasConcept C77411442 @default.
• W2025448962 hasConceptScore W2025448962C126322002 @default.
• W2025448962 hasConceptScore W2025448962C126894567 @default.
• W2025448962 hasConceptScore W2025448962C141071460 @default.
• W2025448962 hasConceptScore W2025448962C2775871022 @default.
• W2025448962 hasConceptScore W2025448962C2777333188 @default.
• W2025448962 hasConceptScore W2025448962C2778508898 @default.
• W2025448962 hasConceptScore W2025448962C2780136519 @default.
• W2025448962 hasConceptScore W2025448962C2780149897 @default.
• W2025448962 hasConceptScore W2025448962C42219234 @default.
• W2025448962 hasConceptScore W2025448962C71924100 @default.
• W2025448962 hasConceptScore W2025448962C77411442 @default.
• W2025448962 hasIssue "1" @default.
• W2025448962 hasLocation W20254489621 @default.
• W2025448962 hasLocation W20254489622 @default.
• W2025448962 hasOpenAccess W2025448962 @default.
• W2025448962 hasPrimaryLocation W20254489621 @default.
• W2025448962 hasRelatedWork W1935363599 @default.
• W2025448962 hasRelatedWork W2025448962 @default.
• W2025448962 hasRelatedWork W2035474551 @default.
• W2025448962 hasRelatedWork W2037835687 @default.
• W2025448962 hasRelatedWork W2067090596 @default.
• W2025448962 hasRelatedWork W2134999210 @default.
• W2025448962 hasRelatedWork W2518961845 @default.
• W2025448962 hasRelatedWork W2807080769 @default.
• W2025448962 hasRelatedWork W2971782675 @default.
• W2025448962 hasRelatedWork W2551863966 @default.
• W2025448962 hasVolume "71" @default.
• W2025448962 isParatext "false" @default.
• W2025448962 isRetracted "false" @default.
• W2025448962 magId "2025448962" @default.
• W2025448962 workType "article" @default.